Literature DB >> 32110640

Regional Wait Times for Patients With Nonmelanoma Skin Cancer in Southwestern Ontario.

Stacy Fan1, Jesse Hackett1, Kristina Lutz1,2, Graham Heaton1,3, Caitlin Symonette1, Aaron Grant1.   

Abstract

BACKGROUND: Nonmelanoma skin cancer (NMSC) affects many Canadians. Although morbidity and mortality are rare, the burden to patients and the health-care system is significant. This study aims to evaluate current plastic surgery wait times and care pathways for patients with NMSC in Southwestern Ontario.
METHODS: A retrospective chart review of 225 patients treated in Ontario from 2015 to 2018 was conducted. Inclusion criteria included patients with an NMSC managed with surgical excision. Referral information was compared. Primary outcomes were wait times: from referral to consultation, referral to excision, and consultation to excision. Data were analyzed using Student t test with equal variance.
RESULTS: One-hundred forty-three patients were included from the academic cohort and 82 from the community cohort. Referrals to academic and community surgeons included lesion location (90% and 97.6%, respectively), but less frequently included size (18% and 29.2%, respectively). Most referrals to academic surgeons included biopsy results (78.6%), as opposed to community referrals (25.6%). Patients in the academic cohort waited 15.3 ± 12.7 weeks from referral to consultation, and 15.7 ± 13 weeks from referral to excision. Patients from the community cohort waited significantly shorter periods of 4.9 ± 3.1 (P < .001) and 11.7 ± 9.9 weeks (P = .016), respectively. However, patients of the academic cohort waited 2.4 ± 7.1 weeks from consultation to excision, while patients in the community cohort waited 6.7 ± 9.6 weeks (P < .001). Rates of negative peripheral margins on pathology were similar between groups, at 89.5% of the academic cohort and 88.9% of the community cohort. Deep margins were positive 5.7% of the time at the academic sites and 6.2% of the time in the community.
CONCLUSIONS: Patients referred to academic centres waited significantly longer periods of time in several parameters compared to those referred to a community surgeon. However, academic surgeons often had expedited consultation-to-excision time frame. This study provides important data for future quality improvement initiatives in NMSC care.
© 2019 The Author(s).

Entities:  

Keywords:  basal cell carcinoma; nonmelanoma skin cancer; referral; squamous cell carcinoma; wait times

Year:  2019        PMID: 32110640      PMCID: PMC7016394          DOI: 10.1177/2292550319880918

Source DB:  PubMed          Journal:  Plast Surg (Oakv)        ISSN: 2292-5503            Impact factor:   0.947


  8 in total

1.  Burden of malignancy after a primary skin cancer: recurrence, multiple skin cancers and second primary cancers.

Authors:  Hans Krueger; Dan Williams
Journal:  Can J Public Health       Date:  2010 Jul-Aug

2.  Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.

Authors:  Robert C Hayes; Suzanne Leonfellner; Wilfred Pilgrim; Jian Liu; Douglas N Keeling
Journal:  J Cutan Med Surg       Date:  2007 Mar-Apr       Impact factor: 2.092

3.  The skin cancer index: clinical responsiveness and predictors of quality of life.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

4.  Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress.

Authors:  George Radiotis; Nicole Roberts; Zofia Czajkowska; Manish Khanna; Annett Körner
Journal:  Oncol Nurs Forum       Date:  2014-01-01       Impact factor: 2.172

5.  What are wait times to see a specialist? an analysis of 26,942 referrals in southwestern Ontario.

Authors:  Amardeep Thind; Moira Stewart; Douglas Manuel; Tom Freeman; Amanda Terry; Vijaya Chevendra; Heather Maddocks; Neil Marshall
Journal:  Healthc Policy       Date:  2012-08

6.  Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin.

Authors:  Joseph Diehl; Young M Choi; Li-Jung Liang; Melvin Chiu
Journal:  Dermatol Surg       Date:  2015-07       Impact factor: 3.398

7.  Quality of life issues in nonmetastatic skin cancer.

Authors:  D Burdon-Jones; P Thomas; R Baker
Journal:  Br J Dermatol       Date:  2009-08-20       Impact factor: 9.302

Review 8.  Quality of life in non-melanoma skin cancer.

Authors:  Charles Gaulin; Deshan F Sebaratnam; Pablo Fernández-Peñas
Journal:  Australas J Dermatol       Date:  2014-09-08       Impact factor: 2.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.